Nifty
:
24624.65
Sensex
:
78581.00
9.75 (0.04%)
152.05 (0.19%)
Nifty
Sensex
:
:
24624.65
78581.00
9.75 (0.04%)
152.05 (0.19%)

Marksans Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :
68/99

BSE: 524404 | NSE: MARKSANS

NSE BSE
270.65
05-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  271
  •  271.8
  •  265
  •  269.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  878439
  •  236220613.35
  •  281.6
  •  155

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 12,258.08
  • 29.12
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 11,298.02
  • 0.33%
  • 4.03

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 43.87%
  • 1.79%
  • 28.05%
  • FII
  • DII
  • Others
  • 17.47%
  • 4.36%
  • 4.46%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.42
  • 14.63
  • 10.66

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 33.70
  • 18.34
  • 5.55

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 47.07
  • 17.76
  • 10.03

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.57
  • 21.57
  • 24.54

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.85
  • 3.20
  • 3.93

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.65
  • 11.98
  • 15.29

Earnings Forecasts:

(Updated: 01-08-2026)
Description
2026
2027
2028
2029
Adj EPS
48
18
24.66
8.61
P/E Ratio
5.64
15.04
10.98
31.43
Revenue
23.63
19.97
15.75
2897.15
EBITDA
3435.48
3938.08
4580
566.1
Net Income
715.9
838.93
1030.5
390.88
ROA
512.55
607.4
768.9
11
P/B Ratio
-0.24
-0.19
-
4.38
ROE
3.44
3.13
2.49
14.38
FCFF
16.03
16.36
-
327.7
FCFF Yield
334.55
426.95
-
2.85
Net Debt
2.91
3.72
-
-916.75
BVPS
-1135.5
-1414
-
61.76

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
856.11
708.46
20.84%
754.43
681.85
10.64%
720.41
641.92
12.23%
619.99
590.62
4.97%
Expenses
660.69
581.52
13.61%
593.69
551.35
7.68%
575.92
495.11
16.32%
519.87
462.18
12.48%
EBITDA
195.42
126.93
53.96%
160.74
130.50
23.17%
144.49
146.81
-1.58%
100.12
128.44
-22.05%
EBIDTM
22.83%
17.92%
21.31%
19.14%
20.06%
22.87%
16.15%
21.75%
Other Income
35.17
15.34
129.27%
20.14
36.11
-44.23%
21.57
-0.07
-
5.64
14.95
-62.27%
Interest
6.31
3.44
83.43%
5.94
2.67
122.47%
5.81
2.63
120.91%
6.06
2.92
107.53%
Depreciation
24.29
22.74
6.82%
24.33
20.69
17.59%
26.92
19.51
37.98%
23.10
20.44
13.01%
PBT
200.00
116.09
72.28%
150.62
143.26
5.14%
133.33
124.60
7.01%
76.60
120.02
-36.18%
Tax
50.97
25.37
100.91%
36.93
38.19
-3.30%
34.20
26.84
27.42%
18.40
30.95
-40.55%
PAT
149.03
90.73
64.26%
113.69
105.07
8.20%
99.14
97.76
1.41%
58.20
89.07
-34.66%
PATM
17.41%
12.81%
15.07%
15.41%
13.76%
15.23%
9.39%
15.08%
EPS
3.27
2.00
63.50%
2.50
2.31
8.23%
2.17
2.13
1.88%
1.29
1.96
-34.18%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
-
2,950.94
2,622.84
2,177.41
1,852.14
1,490.84
1,376.18
1,134.21
1,000.07
912.69
767.16
Net Sales Growth
-
12.51%
20.46%
17.56%
24.23%
8.33%
21.33%
13.41%
9.57%
18.97%
 
Cost Of Goods Sold
-
1,277.28
1,143.74
1,038.12
921.36
716.81
595.05
567.83
498.01
523.13
458.74
Gross Profit
-
1,673.66
1,479.10
1,139.29
930.78
774.02
781.13
566.38
502.07
389.57
308.42
GP Margin
-
56.72%
56.39%
52.32%
50.25%
51.92%
56.76%
49.94%
50.20%
42.68%
40.20%
Total Expenditure
-
2,350.16
2,090.16
1,718.83
1,512.82
1,231.96
1,036.58
941.96
867.93
834.31
734.24
Power & Fuel Cost
-
54.08
40.08
36.94
24.50
18.59
16.42
14.38
14.34
11.83
13.27
% Of Sales
-
1.83%
1.53%
1.70%
1.32%
1.25%
1.19%
1.27%
1.43%
1.30%
1.73%
Employee Cost
-
420.93
350.30
293.64
239.37
220.30
197.32
168.42
159.07
147.75
149.70
% Of Sales
-
14.26%
13.36%
13.49%
12.92%
14.78%
14.34%
14.85%
15.91%
16.19%
19.51%
Manufacturing Exp.
-
155.88
140.08
94.76
96.47
12.73
49.76
64.44
77.14
59.90
47.34
% Of Sales
-
5.28%
5.34%
4.35%
5.21%
0.85%
3.62%
5.68%
7.71%
6.56%
6.17%
General & Admin Exp.
-
109.99
117.60
93.90
52.79
37.74
50.67
45.52
51.03
42.51
37.52
% Of Sales
-
3.73%
4.48%
4.31%
2.85%
2.53%
3.68%
4.01%
5.10%
4.66%
4.89%
Selling & Distn. Exp.
-
260.26
256.64
127.31
133.19
119.05
111.25
81.03
68.36
49.14
27.66
% Of Sales
-
8.82%
9.78%
5.85%
7.19%
7.99%
8.08%
7.14%
6.84%
5.38%
3.61%
Miscellaneous Exp.
-
71.74
41.72
34.16
45.14
106.73
16.10
0.34
0.00
0.05
27.66
% Of Sales
-
2.43%
1.59%
1.57%
2.44%
7.16%
1.17%
0.03%
0%
0.01%
0%
EBITDA
-
600.78
532.68
458.58
339.32
258.88
339.60
192.25
132.14
78.38
32.92
EBITDA Margin
-
20.36%
20.31%
21.06%
18.32%
17.36%
24.68%
16.95%
13.21%
8.59%
4.29%
Other Income
-
82.53
66.33
50.42
59.31
41.85
6.69
0.33
4.63
8.47
18.86
Interest
-
24.13
11.66
11.20
9.13
8.45
7.99
8.75
9.66
10.22
6.79
Depreciation
-
98.63
83.39
74.27
51.85
44.78
36.15
26.66
22.80
26.84
30.09
PBT
-
560.55
503.97
423.53
337.65
247.51
302.16
157.17
104.31
49.80
14.90
Tax
-
140.49
121.35
108.63
72.33
60.70
63.63
36.42
23.87
14.00
3.56
Tax Rate
-
25.06%
24.08%
25.65%
21.42%
24.52%
21.06%
23.17%
22.88%
28.11%
23.89%
PAT
-
417.90
380.58
313.69
266.31
184.56
235.94
117.02
76.46
32.94
8.83
PAT before Minority Interest
-
420.06
382.62
314.89
265.32
186.81
238.54
120.75
80.44
35.80
11.33
Minority Interest
-
-2.16
-2.04
-1.20
0.99
-2.25
-2.60
-3.73
-3.98
-2.86
-2.50
PAT Margin
-
14.16%
14.51%
14.41%
14.38%
12.38%
17.14%
10.32%
7.65%
3.61%
1.15%
PAT Growth
-
9.81%
21.32%
17.79%
44.29%
-21.78%
101.62%
53.05%
132.12%
273.05%
 
EPS
-
9.22
8.40
6.92
5.88
4.07
5.21
2.58
1.69
0.73
0.19

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
3,023.16
2,466.91
2,065.05
1,745.16
1,202.27
886.50
636.01
542.48
470.86
433.43
Share Capital
45.32
45.32
45.32
45.32
40.93
40.93
40.93
40.93
40.93
40.93
Total Reserves
2,974.50
2,421.60
2,019.74
1,699.85
1,068.24
845.56
595.08
501.55
429.93
392.50
Non-Current Liabilities
268.17
272.91
205.20
84.33
57.05
23.70
24.15
17.14
15.64
16.07
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
5.92
5.92
4.56
3.25
1.86
2.11
1.47
1.36
1.08
0.96
Current Liabilities
527.09
477.34
389.85
340.99
380.08
298.97
228.75
232.62
234.68
296.06
Trade Payables
336.91
305.70
268.28
230.60
200.08
168.66
110.33
106.07
77.83
161.78
Other Current Liabilities
118.69
117.17
70.62
42.20
96.80
79.69
58.86
20.90
10.08
0.71
Short Term Borrowings
29.59
23.09
29.09
41.59
41.29
18.74
18.84
99.91
117.41
109.71
Short Term Provisions
41.90
31.39
21.86
26.60
41.92
31.88
40.72
5.74
29.36
23.85
Total Liabilities
3,847.94
3,239.63
2,680.95
2,190.39
1,660.10
1,228.03
902.02
802.46
730.73
751.81
Net Block
1,044.11
981.96
775.94
486.31
428.31
309.36
302.72
269.73
279.38
266.98
Gross Block
1,605.35
1,413.02
1,134.80
828.26
726.26
551.92
565.39
506.26
495.35
456.49
Accumulated Depreciation
561.24
431.06
358.87
341.95
297.96
242.56
262.67
236.54
215.97
189.52
Non Current Assets
1,125.20
1,035.51
818.46
515.09
435.04
325.20
308.45
271.02
280.19
267.92
Capital Work in Progress
58.58
27.11
9.42
9.87
2.57
11.68
0.00
0.00
0.00
0.36
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
22.50
26.27
32.94
18.91
4.16
4.16
5.73
1.29
0.82
0.59
Other Non Current Assets
0.01
0.17
0.17
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
2,722.74
2,204.12
1,862.49
1,675.30
1,225.07
902.82
593.59
531.44
450.54
483.88
Current Investments
0.00
0.74
26.99
0.54
0.44
0.26
0.00
0.00
0.00
0.00
Inventories
972.28
845.52
617.94
484.74
424.44
404.32
241.84
293.25
218.12
190.09
Sundry Debtors
644.57
540.04
453.18
416.85
394.78
271.95
243.35
176.60
176.91
247.58
Cash & Bank
989.65
704.21
673.58
714.96
349.26
212.18
93.73
33.54
39.88
25.16
Other Current Assets
116.25
32.41
30.98
22.74
56.15
14.11
14.66
28.06
15.63
21.05
Short Term Loans & Adv.
76.05
81.20
59.82
35.48
31.79
0.98
3.40
0.00
0.00
20.96
Net Current Assets
2,195.65
1,726.78
1,472.64
1,334.31
844.98
603.85
364.83
298.82
215.86
187.82
Total Assets
3,847.94
3,239.63
2,680.95
2,190.39
1,660.11
1,228.02
902.04
802.46
730.73
751.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
458.13
206.66
230.41
237.41
99.26
178.59
233.33
27.40
50.09
14.06
PBT
560.55
503.97
423.53
337.65
247.51
302.16
157.17
104.31
49.80
14.90
Adjustment
99.68
69.37
55.42
74.24
35.31
56.57
42.04
31.88
43.99
26.58
Changes in Working Capital
-62.46
-240.77
-126.19
-111.47
-110.70
-131.61
59.12
-81.79
-36.23
-6.04
Cash after chg. in Working capital
597.78
332.56
352.76
300.43
172.12
227.12
258.33
54.40
57.56
35.44
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-139.65
-125.90
-122.35
-63.01
-72.86
-48.53
-25.00
-27.00
-7.46
-21.37
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-248.27
-49.01
-140.84
-259.21
-84.39
-44.85
-59.58
-13.48
-38.81
-20.73
Net Fixed Assets
-47.95
-141.06
-91.31
-21.45
-24.09
-28.48
-23.87
-23.07
-5.86
-11.49
Net Investments
-0.72
26.25
-26.45
-29.78
-0.18
-0.26
0.00
0.00
-1.78
-2.85
Others
-199.60
65.80
-23.08
-207.98
-60.12
-16.11
-35.71
9.59
-31.17
-6.39
Cash from Financing Activity
-70.93
-65.15
-68.73
197.83
79.51
-15.29
-113.55
-20.78
3.38
-3.47
Net Cash Inflow / Outflow
138.93
92.51
20.84
176.03
94.38
118.46
60.19
-6.86
14.67
-10.14
Opening Cash & Equivalents
495.79
403.28
382.44
206.41
112.03
93.73
33.54
39.72
25.05
35.30
Closing Cash & Equivalent
634.14
495.79
403.28
382.44
206.41
212.18
93.73
32.85
39.72
25.16

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
66.64
54.44
45.57
38.51
27.10
21.66
15.54
13.25
11.50
10.59
ROA
11.85%
12.93%
12.93%
13.78%
12.94%
22.40%
14.17%
10.49%
4.83%
1.54%
ROE
15.31%
16.89%
16.53%
18.59%
18.72%
31.33%
20.49%
15.88%
7.92%
2.59%
ROCE
21.10%
22.50%
22.40%
22.89%
23.82%
39.76%
25.57%
18.51%
10.60%
3.99%
Fixed Asset Turnover
2.01
2.16
2.33
2.62
2.42
2.49
2.12
2.00
1.92
1.73
Receivable days
71.16
65.99
69.35
72.63
78.56
67.57
67.57
64.51
84.88
110.59
Inventory Days
109.20
97.24
87.89
81.36
97.65
84.73
86.10
93.32
81.63
85.14
Payable days
91.82
91.59
87.70
85.31
93.88
85.57
45.09
38.48
55.10
65.56
Cash Conversion Cycle
88.55
71.65
69.54
68.67
82.33
66.73
108.58
119.35
111.40
130.17
Total Debt/Equity
0.01
0.01
0.01
0.02
0.04
0.02
0.03
0.18
0.25
0.25
Interest Cover
24.24
44.22
38.80
37.99
30.31
38.84
18.97
11.80
5.87
3.20

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Marksans Pharma inks pact to acquire 100% stake in ABCnow GmbH
    8th Jul 2026, 11:19 AM

    The acquisition is expected to be completed by July 31, 2026

    Read More
  • Marksans Pharma inks definitive pact to acquire 100% stake in QliniQ B.V.
    1st Jun 2026, 11:18 AM

    The company will acquire entire shareholding of QliniQ B.V. for a total consideration of 7.50 million euro

    Read More
  • Marksans Pharma - Quarterly Results
    27th May 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.